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ontributions of actin-related proteins (Arp) 2 and
3 nucleotide state to Arp2/3 complex function
were tested using nucleotide-binding pocket (NBP)
mutants in 
 
Saccharomyces cerevisiae
 
. ATP binding by
Arp2 and Arp3 was required for full Arp2/3 complex
nucleation activity in vitro. Analysis of actin dynamics
and endocytosis in mutants demonstrated that nucleotide-
bound Arp3 is particularly important for Arp2/3 complex
function in vivo. Severity of endocytic defects did not cor-
relate with effects on in vitro nucleation activity, suggesting
that a critical Arp2/3 complex function during endocytosis
C
 
may be structural rather than catalytic. A separate class
of Arp2 and Arp3 NBP mutants suppressed phenotypes
of mutants defective for actin nucleation. An Arp2
suppressor mutant increased Arp2/3 nucleation activity.
Electron microscopy of Arp2/3 complex containing this
Arp2 suppressor identiﬁed a structural change that also
occurs upon Arp2/3 activation by nucleation promoting
factors. These data demonstrate the importance of Arp2
and Arp3 nucleotide binding for nucleating activity, and
Arp3 nucleotide binding for maintenance of cortical actin
cytoskeleton cytoarchitecture.
 
Introduction
 
Spatial and temporal regulation of actin polymerization are criti-
cal for cellular processes such as cell migration and endocytosis
(Welch and Mullins, 2002; Engqvist-Goldstein and Drubin,
2003). Because nucleation is rate limiting for actin polymeriza-
tion, regulation of this step controls when and where actin is
assembled in cells. An important nucleator of actin filaments is
the Arp2/3 complex, a seven subunit complex that includes two
actin-related proteins (Arps) 2 and 3 (Welch and Mullins, 2002).
The Arp2/3 complex nucleates actin filaments de novo, and from
the sides of preexisting filaments, generating a branched filament
array (Blanchoin et al., 2000) resembling those observed at the
leading edge of certain motile cells (Svitkina and Borisy, 1999).
Nucleation promoting factors (NPFs), such as members of the
Wiskott-Aldrich syndrome protein (WASP) family of proteins,
activate Arp2/3 complex nucleation activity, allowing regulated
actin assembly that can generate forces in cells (Welch and Mul-
lins, 2002). Elucidating the mechanisms that regulate Arp2/3
complex function is essential for understanding the dynamics of
actin-based force generation.
Nucleotide binding plays a critical role in regulation of
actin dynamics. ATP binding by actin promotes actin filament
assembly by closing the nucleotide-binding pocket (NBP). ATP
hydrolysis and P
 
i
 
 release results in a transition from the “closed”
to the “open” state, promoting actin filament disassembly (Bel-
mont et al., 1999a; Sablin et al., 2002). Similarly, Arp2 and
Arp3 bind ATP, and the Arp2/3 complex requires ATP for nu-
cleation (Dayel et al., 2001; Le Clainche et al., 2001). Arp2
ATP hydrolysis was linked to both the dissociation of actin fila-
ment branches (Le Clainche et al., 2003), and to nucleation
(Dayel and Mullins, 2004). In the crystal structure of nucle-
otide-free Arp2/3 complex, the Arp2 and Arp3 NBPs resemble
that of actin in the “open” conformation (Robinson et al., 2001).
Thus, ATP binding may close the NBPs of Arp2 and Arp3 such
that they can serve as a nucleus for actin polymerization.
In addition to regulating the association of the Arp2/3
complex with actin, nucleotide binding by Arp2/3 complex is
linked to NPF binding. ATP-bound Arp2/3 exhibits higher
affinity  for NPFs than ADP-bound complex (Dayel et al.,
2001). Furthermore, Arp2 ATP binding was reported to be
enhanced by NPFs, and to be required for efficient Arp2/3
complex activation (Le Clainche et al., 2001). Similar to ATP,
actin filaments also enhance Arp2/3 complex affinity for NPFs
(Marchand et al., 2001). Because Arp2 and Arp3 are splayed
apart in the crystal structure of the inactive Arp2/3 complex
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(Robinson et al., 2001), it is possible that the cooperative binding
of ATP, NPFs, and actin filaments bring Arp2 and Arp3 together
to form a template dimer for nucleation. Cryo-electron micros-
copy of the Arp2/3 complex in actin filament branches revealed
that a large conformational change in the Arp2/3 complex repre-
sented in the crystal model is required for Arp2/3 activation
(Volkmann et al., 2001). These conformational changes are
likely to be influenced by the nucleotide state of Arp2 and Arp3.
Although ATP has been demonstrated to be important for
Arp2/3 nucleation in vitro, the contributions of ATP-bound
Arp2 or Arp3 to in vitro and in vivo function have not been de-
termined individually. Here, we generated NPB mutations of 
 
S.
cerevisiae
 
 Arp2 and Arp3 to explore the individual contribu-
tions of nucleotide to the function of each protein.
 
Results
 
Identification of Arp2 and Arp3 mutants 
that affect nucleotide binding
 
To test the function of ATP binding by Arp2 and Arp3, we gen-
erated 26 site-directed mutations that changed conserved resi-
dues in the NBPs of these two proteins (Fig. 1; Table S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200408177/DC1).
We attempted to make mutations that would affect nucleotide
affinity, hydrolysis, and exchange. Mutants were chosen based
on previous mutations of actin (Wertman et al., 1992; Chen et
al., 1995; Belmont and Drubin, 1998; Belmont et al., 1999b)
and on predictions based on the actin crystal structure (Kabsch
et al., 1990; Vorobiev et al., 2003). Residue numbers used to
refer to mutants correspond to the amino acid position in the
yeast actin sequence. Mutants were integrated into the endoge-
nous 
 
ARP2
 
 and 
 
ARP3
 
 chromosomal loci and were assessed for
growth on different media (Table S1). Immunoblotting re-
vealed that mutants expressed wild-type levels of Arp2 and
Arp3 (unpublished data). Although viable 
 
arp2
 
 
 
 and 
 
arp3
 
 
 
mutant strains have been observed (Winter et al., 1999), dele-
tion of either gene resulted in lethality under our growth condi-
tions. Surprisingly, all but one of the integrated Arp2 and Arp3
mutants were viable, suggesting that they retain partial func-
tion, and allowing further characterization of their effects.
Because ATP is required for Arp2/3 nucleation activity in
vitro (Dayel et al., 2001; Le Clainche et al., 2001), we predicted
that mutants affecting ATP binding would decrease Arp2/3
function in vivo. Two mutants predicted to lower nucleotide
binding affinity, 
 
arp3-D11A
 
 and 
 
arp3-G302Y
 
, showed growth
defects at high temperature and high osmolarity (Table S1). The
 
arp3-D11A
 
 mutant was predicted to lower nucleotide affinity by
removing an aspartic acid that interacts with divalent cation,
Figure 1. Arp2 and Arp3 residues chosen for mutagenesis. Crystal structure of actin and NBPs of actin, Arp2, and Arp3 (Kabsch et al., 1990; Robinson et al.,
2001). Subdomains of actin are indicated with Roman numerals. Because subdomains I and II of Arp2 are not present in the crystal structure, the backbone of
actin was substituted. Altered residues, ATP (blue), and Ca
2  (orange) are identified by colors. Residue numbers correspond to the yeast actin peptide sequence. 
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whereas the 
 
arp3-G302Y
 
 mutant was predicted to prevent nucle-
otide binding by introducing a tyrosine into the adenine-binding
pocket. Interestingly, the analogous Arp2 mutations, 
 
arp2-D11A
 
and 
 
arp2-G302Y
 
, exhibited less severe growth phenotypes. To
further analyze the effects of these mutants, we crossed 
 
arp3-
G302Y
 
 and 
 
arp2-G302Y
 
 to several 
 
arp2
 
 and 
 
arp3
 
 alleles, re-
spectively. In addition, we crossed these mutants to 
 
las17-11
 
,
a temperature-sensitive allele of the gene encoding a yeast
WASP-like NPF (Duncan et al., 2001). 
 
arp2-G302Y
 
 and 
 
arp3-
G302Y
 
 showed synthetic lethality with each other and with
 
las17-11
 
 (Table I). In addition, 
 
arp2-G302Y
 
 and 
 
arp3-G302Y
 
exhibited synthetic lethality with 
 
arp3-D11A
 
 and 
 
arp2-D11A
 
,
respectively (Table I). Thus, the 
 
arp2-D11A, arp3-D11A, arp2-
G302Y,
 
 and 
 
arp3-G302Y
 
 mutants impaired Arp2/3 function in
vivo, possibly indicating a defect in nucleotide binding.
Surprisingly, we identified two mutants, 
 
arp2-D157E
 
and 
 
arp2-Y306A,
 
 that partially suppressed the 
 
arp3-G302Y
 
phenotype, with 
 
arp2-Y306A
 
 being the stronger suppressor
(Table I). Suppression was not allele specific because 
 
arp2-
Y306A
 
 also partially suppressed 
 
arp3-D11A
 
 and 
 
las17-11
 
 (Ta-
ble I). In addition, 
 
arp2-Y306A
 
 exhibited intragenic suppres-
sion of 
 
arp2-G13C
 
 (Table I). The analogous Arp3 mutation,
 
arp3-F306A,
 
 suppressed both 
 
arp2-D11A
 
 and 
 
arp3-G15C
 
(Table I). Thus, 
 
arp2-Y306A
 
 and 
 
arp3-F306A
 
 represented a
class of NBP mutant that appeared to increase the activity of
the Arp2/3 complex.
 
ATP binding to Arp2 and Arp3 mutants
 
To determine if the 
 
D11A
 
, 
 
G302Y
 
, and 
 
Y(F)306A
 
 mutations af-
fected nucleotide binding, we purified the Arp2/3 complex
from these mutants (Fig. 2 A). Similar amounts of purified pro-
tein were obtained for each strain and most of these mutant
complexes showed normal subunit compositions. However, we
were unable to determine the stoichiometry of Arc40 due to its
abnormal mobility on SDS-PAGE gels (Pan et al., 2004). Inter-
estingly, Arp2/3 complex from 
 
arp2-D11A
 
 exhibited notice-
able Arp3 degradation, indicating that Arp2 can contribute to
the stability of Arp3 (Fig. 2 A).
The ability of mutant complexes to bind ATP was as-
sessed using a photo-cross-linking assay previously used to ex-
amine ATP binding to the Arp2/3 complex (Dayel et al., 2001;
Le Clainche et al., 2001). For wild-type yeast Arp2/3 complex,
 
 
 
-[
 
32
 
P]ATP was cross-linked to Arp2 and Arp3, and addition of
the Arp2/3-activating WCA domain of Las17 did not substan-
tially affect this cross-linking, similar to what was observed for
 
Acanthamoeba
 
 Arp2/3 complex (Fig. 2 B; Dayel et al., 2001).
The 
 
arp2-G302Y
 
 and 
 
arp3-G302Y
 
 mutations dramatically
decreased ATP cross-linking to Arp2 and Arp3, respectively,
which is consistent with the prediction that this change steri-
cally inhibits nucleotide binding (Fig. 2 B). These mutations did
not affect ATP cross-linking by the nonmutated Arp subunit,
suggesting that ATP binding by Arp2 and Arp3 are indepen-
dent, although we cannot rule out subtle effects on conforma-
tion. Surprisingly, the 
 
arp2-Y306A
 
 and 
 
arp3-F306A
 
 mutations
also decreased ATP cross-linking to Arp2 and Arp3, respec-
tively, despite their ability to suppress other mutants. However,
Arp2-Y306A ATP cross-linking was reproducibly increased to
 
 
 
70% of wild type by Las17 WCA (Fig. 2 B). The 
 
arp2-D11A
 
and 
 
arp3-D11A
 
 mutations had a lesser effect on nucleotide
cross-linking, suggesting that these mutants have milder effects
on ATP binding (Fig. 2 B).
We confirmed the ATP binding defects of our mutants us-
ing a fluorescent derivative of ATP, etheno-ATP, which in-
creases in fluorescence upon binding to the Arp2/3 complex. Al-
though this assay is more quantitative than the cross-linking
assay, it cannot be used to distinguish between binding to Arp2
or Arp3 in the wild-type Arp2/3 complex. We found that wild-
type yeast Arp2/3 complex binds to etheno-ATP with a 
 
K
 
d
 
 of
2.3 
 
 
 
M (Fig. 2 C). Arp2/3 complex from 
 
arp3-G302Y
 
 and 
 
arp3-
F306A
 
 was saturated with etheno-ATP at 
 
 
 
25% the fluo-
rescence of wild-type Arp2/3 complex, further suggesting that
Arp3-G302Y and Arp3-F306A did not bind ATP under these
 
Table I. 
 
Genetic interactions of Arp2 and Arp3 mutants
 
arp2-G302Y[WT] x
 
Double mutant phenotype
 
arp3-G302Y[ts, ss, fs] x
 
Double mutant phenotype
 
arp3-D11A
 
SL
 
arp2-D11A
 
SL
 
arp3-T14A
 
SS (37
 
 
 
C)
 
arp2-T14A
 
SS (30
 
 
 
C)
 
arp3-Q137A
 
nd
 
arp2-Q137A
 
NE
 
arp3-Q137E
 
nd
 
arp2-Q137E
 
SS (25
 
 
 
C)
 
arp3-D157E
 
SS (NaCl)
 
arp2-D157E
 
a
 
Sup (fs)
 
arp3-V159N
 
NE
 
arp2-V159N
 
NE
 
arp3-G302Y
 
SL
 
arp2-G302Y
 
SL
 
arp3-F306A
 
NE
 
arp2-Y306A
 
a
 
Sup (ts,fs)
 
las17-11
 
SL
 
las17-11
 
SL
 
arp2-Y306A[WT] x
 
Double mutant phenotype
 
arp3-F306A[WT] x
 
Double mutant phenotype
 
arp3-D11A
 
Sup (ss, fs)
 
arp2-D11A
 
Sup (ss)
 
arp2-G13C
 
b
 
Sup (ts, fs)
 
arp3-G15C
 
b
 
Sup (ss, fs)
 
las17-11
 
Sup (fs)
 
las17-11 SS (30 C)
Genetic interactions were examined by dissecting at least seven tetrads for each cross and identifying double mutants using linked auxotrophic markers. The phenotypes
of starting strains are shown in brackets. SL, synthetic lethal at 25 C; SS, synthetic sick; NE, no effect; Sup, suppression; ts, temperature sensitive; ss, salt sensitive; fs,
formamide sensitive; nd, not determined. Growth under the condition shown in parentheses changes in the double mutant.
aSuppression is of arp3-G302Y phenotype.
bIntragenic interaction.JCB • VOLUME 168 • NUMBER 2 • 2005 318
conditions (Fig. 2 C). The residual fluorescence increase is likely
due to Arp2 etheno-ATP binding, with a calculated Kd of  20
 M. This value agrees with previous results showing a low af-
finity of Arp2 for ATP in the absence of an NPF (Le Clainche et
al., 2001). arp3-D11A Arp2/3 complex showed a greater fluores-
cence increase, but exhibited a 15-fold higher Kd, suggesting that
Arp3-D11A bound etheno-ATP with lower affinity (Fig. 2 C). In
contrast,  arp2 mutant complexes exhibited similar affinity to
wild-type Arp2/3 complex and only moderately decreased the
fluorescence at saturation (Fig. 2 D). Thus, the fluorescence in-
crease is mostly due to Arp3 etheno-ATP binding, with a calcu-
lated Kd of  2  M, similar to the previously determined value
(Dayel et al., 2001). Overall, the cross-linking and etheno-ATP
binding experiments demonstrated that the D11A, G302Y, and
Y(F)306A mutants lower the affinity of Arp2 and Arp3 for ATP,
with the G302Y mutant being most severely defective.
Arp3 nucleotide binding is required for 
normal actin organization and 
endocytosis
The Arp2/3 complex localizes to yeast cortical actin patches
(Moreau et al., 1996; Winter et al., 1997), and Arp2/3 complex
mutants show defects in actin patch polarity (Moreau et al.,
1996; Madania et al., 1999; Winter et al., 1999) and in endocy-
tosis (Moreau et al., 1996, 1997). To test the importance of
Arp2 and Arp3 nucleotide binding in vivo, we first examined
actin cytoskeleton organization in fixed cells using rhodamine
phalloidin. At 25 C, actin patches in arp2-D11A, arp3-D11A,
and arp3-G302Y mutants were more depolarized than in wild-
type cells (Fig. 3 A, Table II). In addition,  10–20% of arp3-
G302Y cells and a few percent of arp2-D11A and arp3-D11A
cells exhibited cable-like actin aggregates, similar to those pre-
viously observed in arp3-2 mutant cells (Winter et al., 1997).
Actin patches became almost completely depolarized when
arp3-D11A and arp3-G302Y cells were shifted to the restric-
tive temperature of 37 C for 1 h (Fig. 3 A). Consistent with
previous findings (Winter et al., 1999), actin cables were
present in all mutants at all temperatures. In contrast to arp3-
G302Y, actin patches in arp2-G302Y were of normal size and
were polarized at both 25 C and 37 C (Fig. 3 A). The Arp2/3
complex localized to actin patches in both arp2 and arp3 mu-
tants, although with slightly less intensity than in wild-type
cells (Fig. 3 B). We were unable to examine arp3-G302Y local-
ization because of synthetic sickness with HA-tagged ARC18.
Figure 2. ATP binding of Arp2 and Arp3 mutants. (A) Coomassie staining of purified mutant Arp2/3 complexes. Asterisk indicates Arp3 degradation.
(B) ATP cross-linking to purified Arp2/3 complex mutants. Arp2/3 complex subunits were separated by SDS-PAGE and visualized by autoradiography
(top) and Coomassie staining (bottom). Asterisks indicate Arp3 degradation. See Table II for quantification. (C and D) Etheno-ATP binding to purified
Arp2/3 complex mutants. Data points represent averages   SEM from two experiments. See Table II for Kd values.GENETIC DISSECTION OF ATP BINDING BY ARP2/3 COMPLEX • MARTIN ET AL. 319
Interestingly, actin organization and Arp2/3 localization in
arp2-Y306A and arp3-F306A mutants were indistinguishable
from wild type (unpublished data), suggesting that these mu-
tants did not decrease Arp2/3 activity.
Because the Arp2/3 complex and actin patches have
been implicated in yeast endocytosis (Moreau et al., 1996,
1997; Kaksonen et al., 2003), we tested endocytic function by
visualizing uptake of the fluid phase dye, Lucifer yellow (LY)
at 25 C. The arp3-D11A and arp3-G302Y mutants showed a
dramatic reduction in LY staining in the vacuole (Fig. 3 C).
However, the arp2-Y306A and arp3-F306A mutants showed
similar LY internalization to wild-type cells (Table II). The
arp2-Y306A mutant suppressed the LY internalization defect
of arp3-G302Y (Fig. 3 C). Importantly, LY uptake was only
moderately impaired in arp2-G302Y and arp2-D11A mutant
cells, which is consistent with the more mild effect on growth
and actin organization (Fig. 3 C). Therefore, Arp3 nucleotide
binding is more important compared with Arp2 nucleotide
binding for endocytosis, the major function of cortical actin
patches.
Figure 3. Actin cytoskeleton and endocytosis defects of Arp2 and Arp3 mutants. (A) Rhodamine phalloidin staining of yeast expressing indicated Arp2
and Arp3 mutants. Cells were grown at 25 C, or shifted to 37 C for 1 h. Arrows indicate depolarized cells. Arrowheads indicate abnormal actin aggregates.
(B) Arp2/3 complex localization in Arp2 and Arp3 mutants. Actin and Arp2/3 were visualized by indirect immunofluorescence after growth at 25 C.
HA-tagged Arc18 was used to immunolocalize the Arp2/3 complex. Arrowheads indicate examples of colocalization. (C) Analysis of endocytosis by
fluorescence microscopy using LY uptake. Cells were incubated with LY for 1 h at 25 C. Quantification is in Table II.JCB • VOLUME 168 • NUMBER 2 • 2005 320
Arp3 nucleotide binding is required for 
Abp1 and Sla1 internalization
We next determined which steps in endocytic internalization
are affected in Arp3 mutants. An endocytic pathway has been
elucidated in which the behavior of yeast cortical patches is
correlated with invariant changes in the protein composition of
these patches over time (Kaksonen et al., 2003). Early compo-
nents of this pathway, such as the endocytic adaptor Sla1, as-
semble as patches at the plasma membrane and remain stably
associated with the membrane until they are internalized after
 20–30 s. Late patch components, such as actin, Arp2/3 com-
plex, and the actin filament binding protein, Abp1, are re-
cruited to Sla1 containing patches later, and movement of actin
and Abp1 off the plasma membrane coincides with Sla1 inter-
nalization. The Arp2/3 complex has previously been shown to
be important for actin patch motility (Winter et al., 1997), but
its importance in the context of the recently defined endocytic
pathway had not yet been investigated.
Abp1-GFP, a marker for filamentous actin, and Sla1-
GFP were crossed to the D11A, G302Y, and Y(F)306A mu-
tants to visualize the dynamics of these proteins in live mutant
cells. Similar results were obtained using either Sac6-GFP or
Abp1-GFP as a marker for actin (unpublished data), demon-
strating that Abp1-GFP is a suitable marker for filamentous
actin in these cells. The arp2-D11A, arp3-D11A, and arp3-
G302Y mutants significantly decreased internalization of both
Abp1 and Sla1 patches at 25 C (Fig. 4, A and B; Table II; Vid-
eos 1 and 2, available at http://www.jcb.org/cgi/content/full/
jcb.200408177/DC1).  This internalization defect resulted in
significantly longer lifetimes for Sla1 cortical patches in these
arp2 and arp3 mutants (Table II). In contrast, internalization
of Abp1 and Sla1 patches was only moderately reduced in the
arp2-G302Y mutant (Fig. 4, A and B, Videos 1 and 2). Thus,
Abp1 and Sla1 internalization defects correlated with endocy-
tosis defects observed by LY uptake, which is consistent with
the conclusion that patch internalization represents endocytic
internalization (Kaksonen et al., 2003). The arp2-Y306A mu-
tant, while exhibiting wild-type Abp1 and Sla1 patch inter-
nalization, partially suppressed the internalization defects of
arp3-G302Y, which is consistent with its suppression of the
LY internalization defect (Fig. 4 A, Table II).
The internalization defects of Arp3 mutants could have
resulted from loss of spatial or temporal regulation of actin
assembly at endocytic sites. Interestingly, the rate of Abp1
patch assembly was slightly decreased in both arp2-G302Y
and arp3-G302Y (Fig. 4 C), resulting in longer Abp1 patch
lifetimes in these mutants (Table II). In addition, the onset of
actin assembly was significantly delayed in both arp2-
G302Y and arp3-G302Y relative to the initial appearance of
Sla1 patches (Fig. 4 D). Thus, nucleotide-bound Arp2 and
Arp3 are required to initiate actin polymerization at en-
docytic sites with the proper timing. However, the internal-
ization defects observed in arp3-G302Y could not be explained
by actin assembly defects.
Arp2 and Arp3 mutants form defective 
actin comet tails in sla2  mutants
To further investigate the basis for the Arp3 mutant internal-
ization defect, we analyzed the effects of the arp2-G302Y
and arp3-G302Y mutants on actin polymerization at endo-
cytic sites by taking advantage of the sla2  mutant pheno-
type. Deletion of the SLA2 gene blocks Sla1 internalization
and results in the formation of actin comet tails that associate
with Sla1-containing patches at the plasma membrane (Kak-
sonen et al., 2003). Clusters of actin comet tails can be ob-
served in sla2  cells expressing GFP-tagged actin, and the
treadmilling rate can be measured by the directional FRAP
(Kaksonen et al., 2003).
Surprisingly, photo-bleaching of actin comet tails in
sla2  arp2-G302Y or sla2  arp3-G302Y mutants revealed that
Table II. Summary of Arp2 and Arp3 mutant biochemical and cellular phenotypes
Allele Growth ATP cross-linking Etheno-ATP Actin polarization LY uptake
Abp1 motility
(lifetime)
Sla1 motility
(lifetime) Nucleation activity
%K d ( M) % % % %
WT   100 2.3   0.1 98 (90) 97 94.5   2.1
(15   3 s)
85.4   5.1
(33   10 s)
1.0
arp2-D11A ss 82.8 2.0   0.1 72 (59) 57 21.5   5.4 9.2   4.4 0.11
arp2-G302Y   16.9 1.8   0.1 98 (90) 91 75.9   8.2
(24   5 s)
51.5   1.3
(69   24 s)
0.28
arp2-Y306A   23.1 2.4   0.2 nd 97 94.3   3.4 89.1   3.5
(33   8 s)
1.12
arp3-D11A ts, fs, ss 68.1 34.5   2.2 43 (7) 14 14.5   9.4 3.3   2.9 0.28
arp3-G302Y ts, fs, ss 17.1 22.0   4.4 18 (4) 15 6.2   4.9
(29   6 s)
1.7   2.9
(148   52 s)
0.24
arp3-F306A   29.5 16.7   4.2 nd 88 94.3   3.0 78.2   1.7 0.96
arp3-Y306A; 
arp3-G302Y
ss nd 1.5   10
6 nd 85 21.8   1.7
(29   6 s)
11.0   9.3
(98   27 s)
0.21
Characterization of Arp2 and Arp3 nucleotide-binding mutants. Growth: growth phenotypes on different media. ts, temperature sensitive (37°C); ss, salt sensitive; fs,
formamide sensitive. ATP cross-linking: % of wild-type signal in the absence of WCA on Arp2 for arp2 mutants and Arp3 for arp3 mutants. Etheno-ATP Kd: average
Kd   SEM calculated from data in Fig. 2 (C and D) as described in Materials and methods. Actin polarization: calculated as % of small-budded cells containing  5
patches in the rear of the mother cell at 25°C and 37°C (parentheses). Actin was visualized with rhodamine phalloidin. LY (Lucifer yellow) uptake: measured visually
as the % of the cells exhibiting bright vacuolar staining (Fig. 3 C, WT) versus faint or lack of staining (Fig. 3 C, arp3-G302Y). Abp1 motility and Sla1 motility: average
% of motile patches   SD as determined from at least 60 patches for each strain. Parentheses: average lifespan   SD of patches in seconds as determined from at
least 20 patches for each strain. Nucleation activity: fraction of barbed ends generated relative to wild type. nd, not determined.GENETIC DISSECTION OF ATP BINDING BY ARP2/3 COMPLEX • MARTIN ET AL. 321
the rate of actin treadmilling was only slightly reduced com-
pared with the rate in wild-type cells (Fig. 5 A). This was
consistent with the relatively normal assembly of actin at en-
docytic sites described above. Importantly, however, the con-
tinuity of actin tails in sla2  arp3-G302Y cells was se-
verely disrupted. Whereas actin tails in sla2  mutants appeared
smooth and continuous, all sla2  arp3-G302Y actin tails ex-
hibited a broken structure (Fig. 5 B, Video 3, available at http:
//www.jcb.org/cgi/content/full/jcb.200408177/DC1). In these
mutants, clumps of actin appeared to separate from the plasma
membrane and to move into the cytoplasm at a continuous rate
(Fig. 5 C). This phenotype was also observed for 40% of sla2 
Figure 4. Arp2 and Arp3 mutants affect actin patch protein internalization. (A) Tracking of individual cortical Abp1 patches. Abp1-GFP was visualized
every 0.25 s and patch movement traces were obtained for the entire life of patches. Green and red dots indicate first and last positions, respectively.
Dotted line indicates plasma membrane. (B) Internalization of Sla1 patches. Single frames (left) and kymographs (right) of time-lapse images collected at
0.5-s intervals using a line drawn perpendicular to the plasma membrane (e.g., yellow). Dotted line: plasma membrane. (C) Fluorescence intensity of indi-
vidual Abp1-GFP patches measured over time. (D) Single frames (left) and time series of single cortical patches (right) of cells expressing Abp1-GFP (red)
and Sla1-CFP (green). Time-lapse between images was  4.55 s. Average times and SDs between Sla1 appearance and Abp1 recruitment were calculated
from at least 20 patches.JCB • VOLUME 168 • NUMBER 2 • 2005 322
arp2-G302Y tails (Fig. 5 B and C), although the remaining tails
appeared similar to wild-type. Thus, the arp3-G302Y mutant,
which has an endocytic internalization defect, more severely
affected the continuity of actin comet tails.
In vitro nucleation activity of Arp2 and 
Arp3 mutants
To determine whether the more severe endocytic defects of
Arp3 mutants versus Arp2 mutants reflected lower Arp2/3
nucleation activity, we used the pyrene-actin assembly as-
say. The in vitro nucleation activity of mutant Arp2/3 com-
plexes activated by full-length Las17 (Rodal et al., 2003)
was examined. Unless otherwise noted, we used 500  M
ATP in our assays to approximate physiological conditions.
Surprisingly, the Arp2/3 complex from arp2-G302Y, which
had only a subtle effect in cells, and the Arp2/3 complex
from arp3-G302Y and arp3-D11A, which caused severe ef-
fects in cells, exhibited a similar decrease in activity (Fig. 6,
A and B). The nucleation activity of these mutant Arp2/3
complexes was equivalent to that exhibited when the concen-
tration of wild-type Arp2/3 complex was lowered 20-fold
(Fig. 6 A). Arp2/3 complex from arp2-D11A showed the
lowest nucleation activity, which is consistent with this mu-
tant affecting Arp3 stability as well as Arp2 nucleotide bind-
ing (Fig. 6 B). The nucleation activities of arp2-G302Y and
arp3-G302Y Arp2/3 complex were similar to each other with
different concentrations of NPF, nucleotide, and actin, as
well as with the NPFs Pan1 and Abp1 (Fig. 6, B and C, not
depicted). In addition, arp2-G302Y and arp3-G302Y Arp2/3
complexes exhibited a similar reduction in the number of
Y-branches formed compared with wild-type Arp2/3 com-
plex (Fig. 6 D). Therefore, the endocytic defects of the arp3-
G302Y mutant did not correlate with effects on Arp2/3 nu-
cleation or branch formation activities.
Interestingly, we found that whereas wild-type Arp2/3 nu-
cleation activity was saturated at 200 nM Las17, arp2-G302Y
and arp3-G302Y were not, suggesting that these mutants might
decrease nucleation activity in part by lowering the affinity for
NPF (Fig. 6 B). To test this hypothesis, we pulled down Arp2/3
complex with various amounts of WCA-coated beads. Wild-
type Arp2/3 complex bound Las17 WCA with a Kd of  4  M,
slightly higher than that reported for WCA from WASP and
N-WASP (0.2–2  M; Dayel et al., 2001; Le Clainche et al.,
2001; Marchand et al., 2001; Panchal et al., 2003). Surprisingly,
both arp2-G302Y and arp3-G302Y Arp2/3 complexes bound
Las17 WCA with similar affinity to the wild-type Arp2/3 com-
plex (Fig. 6 E). Furthermore, neither arp2-G302Y nor arp3-
G302Y significantly affected Arp2/3 affinity for the sides of ac-
tin filaments (unpublished data). Thus, the low activity of these
mutants was not due to reduced NPF affinity.
Because arp2-Y306A and arp3-F306A suppressed Arp2/3
mutant phenotypes in vivo, we purified Arp2/3 complex from
arp2-Y306A and arp3-F306A to determine the biochemical ba-
sis for this suppression. Despite lowering affinity for ATP (Fig.
2), arp3-F306A Arp2/3 complex exhibited wild-type nucleation
activity, whereas the arp2-Y306A Arp2/3 complex increased
nucleation activity with the NPF Las17, exhibiting an activ-
ity equivalent to a fourfold higher concentration of wild-type
Arp2/3 complex (Fig. 6, B and F). In addition, arp2-Y306A ex-
hibited two- to fourfold higher activity in the absence of an NPF,
similar to that of wild-type Arp2/3 complex activated with the
less active Las17 WCA (Fig. 6 G). Despite this increase in ac-
tivity, the arp2-Y306A mutant did not restore nucleation activity
to Arp2/3 complex containing arp3-G302Y (Fig. 6 H), and it failed
Figure 5. Arp2 and Arp3 mutants affect the continuity
of  sla2  actin comet tails. (A) Quantification of actin
treadmilling rates using FRAP in sla2  cells expressing
the indicated Arp mutant and Act1-GFP. Average tread-
milling rates and SDs were calculated from 10 separate
actin tail clusters. (B) Confocal images of whole cells (left)
and magnified views of actin comet tail clusters (right).
Arrowheads indicate actin clumps. (C) Kymograph of
time-lapse images collected at 1-s intervals using a line
drawn perpendicular to the plasma membrane (e.g.,
gray line, B). A section of the actin comet tail cluster
(e.g., white box, B) was photo-bleached after 10 s. Arrow-
heads indicate where the actin network appears to sepa-
rate from the plasma membrane.GENETIC DISSECTION OF ATP BINDING BY ARP2/3 COMPLEX • MARTIN ET AL. 323
Figure 6. Effects of Arp2 and Arp3 mutants on Arp2/3 complex nucleation and branching. (A and F–H) Nucleation activity of Arp2 and Arp3 mutants.
2  M actin (5% pyrene labeled) was polymerized with the indicated concentration of Arp2/3 complex and, when indicated, 50 nM Las17 or 400 nM
WCA. 500  M ATP was present in nucleation reactions unless otherwise stated. (B and C) Barbed end concentrations at 50% polymerization generated
by Arp2/3 (20 nM) and different concentrations of Las17 (B) or with 50 nM Las17 and 7, 57, 107, or 507  M ATP (C). (D) Branching activity of Arp2
and Arp3 mutants. Actin filaments polymerized with 20 nM mutant Arp2/3 complex (2 nM wild-type Arp2/3) and 200 nM Las17 were visualized with
rhodamine phalloidin. Average branching efficiency   SD was calculated as branch number per micrometer filament length, corrected for differences in
nucleation activity. (E) WCA binding to Arp2/3 complex mutants. 40 nM Arp2/3 complex was incubated with various concentrations of Las17 WCA-
coated beads and the fraction of bound Arp2/3 was calculated by quantifying Arp3 left in the supernatant by immunoblotting. Data points represent av-
erages   SEM from three experiments. Kd values of 4.5   0.9  m, 3.9   1.0  m, and 4.5   1.0  m were calculated for wild-type, arp2-G302Y, and
arp3-G302Y Arp2/3 complexes, respectively.JCB • VOLUME 168 • NUMBER 2 • 2005 324
to rescue Arp3 nucleotide binding of arp3-G302Y (Fig. 2 C),
suggesting that in vivo suppression by the arp2-Y306A mutant
does not simply restore nucleotide binding to Arp3.
The arp2-Y306A suppressor results in a 
conformational change that mimics 
Arp2/3 complex activation
We next used electron microscopy and image analysis to identify
conformational changes that occur upon activation of wild-type
Arp2/3 complex. In addition, because the Arp2/3 complex con-
taining the arp2-Y306A mutant exhibited constitutive activity
similar to wild-type Arp2/3 complex activated by Las17 WCA
(Fig. 6 G), we tested whether the arp2-Y306A mutation mimics
the Arp2/3 complex activation step induced by NPF binding.
Non-activated wild-type Arp2/3 complex, the arp2-Y306A Arp2/3
mutant, and wild-type Arp2/3 complex bound to Las17 WCA,
were imaged by electron microscopy in negative stain (Fig. 7).
Single-particle analysis resulted in three reconstructions at  2.5
nm resolution (Fig. 7 E), considerably higher than the 3.9 nm
resolution previously reported for the yeast Arp2/3 complex
(Volkmann et al., 2001). Fitting the atomic model of the nonacti-
vated bovine Arp2/3 complex (Robinson et al., 2001) into the
three-dimensional maps revealed that the overall morphology of
all three reconstructions resembles that of the crystal structure
(Fig. 7 A). However, differences in the density distribution be-
tween the activated and the nonactivated wild-type Arp2/3 re-
constructions are clearly visible in the Arp2 and Arc15 regions
(Fig. 7, B and D). This observation shows for the first time a
distinct structural change upon Arp2/3 complex activation by
WCA. Interestingly, no significant differences were observed
when the nonactivated arp2-Y306A mutant reconstruction was
compared with the activated wild-type Arp2/3 map. Thus, the
structural changes induced by NPF binding in the wild-type
Arp2/3 complex are similar to those observed in the mutant com-
plex in the absence of NPF. These structural similarities explain
the close resemblance of the nucleation activities of the mutant
and the activated wild-type Arp2/3 complex (Fig. 6 G) and sug-
gest that arp2-Y306A suppresses other mutants by causing the
Arp2/3 complex to resemble the active conformation.
Discussion
We have generated mutants that affect either Arp2 or Arp3 nu-
cleotide binding. Based on the effects of these mutants on en-
Figure 7. Single-particle reconstructions of Arp2/3
complexes. (A) Docking of the nonactivated bovine
Arp2/3 crystal structure (ribbon diagram) into the recon-
struction of nonactivated wild-type yeast Arp2/3 complex
(chicken-wire representation). Color scheme follows C.
The view in the second row is rotated by 90  horizon-
tally from that in the first row; the view in the third row is
rotated by 180  horizontally from that in the first row.
(B) Three views of the reconstructions (solid blue surface
representation) from nonactivated wild-type Arp2/3
complex (WT), nonactivated arp2-Y306A mutant (arp2-
Y306A), and activated wild-type Arp2/3 complex (WT-
WCA). The views match those in A. Red arrows indicate
the region of Arp2 that shows differences between WT
and WT-WCA/arp2-Y306A. Gray arrows indicate the
differences in the Arc15 region. (C) Solvent exposed sur-
face of the crystal structure; view matches third row in A.
(D) Projection views of the three Arp2/3 reconstructions.
Red arrows indicate the Arp2 region, highlighting differ-
ences seen in B. (E) Fourier shell correlation graphs for
the three reconstructions calculated from two randomly
selected half sets of each respective data set. The 0.5 crite-
rion indicates  2.5 nm resolution for all reconstructions.GENETIC DISSECTION OF ATP BINDING BY ARP2/3 COMPLEX • MARTIN ET AL. 325
docytosis and in vitro nucleation activity, we present a model
for the functions of nucleotide-bound Arp2 and Arp3 in Fig. 8.
First, ATP-bound Arp2 and Arp3 are both required for full acti-
vation of the Arp2/3 complex by NPFs in vitro (Fig. 8 A).
Moreover, a structural change in Arp2 accompanies activation
of the Arp2/3 complex by an NPF, as observed by electron mi-
croscopy. The resulting nucleation activity is important for ef-
ficiently initiating actin polymerization at endocytic sites (Fig.
8 B, i). Once actin filaments are nucleated, actin assembly can
proceed, albeit more slowly, with minimal Arp2/3 nucleation
activity. Finally, Arp2/3 complex, particularly nucleotide bind-
ing by Arp3, plays a yet to be defined role, possibly anchoring
actin filaments to each other and to the plasma membrane, to
allow polymerization forces to be harnessed for endocytic in-
ternalization (Fig. 8, A and B, ii). The evidence supporting this
model is discussed below.
Importance of Arp2 and Arp3 nucleotide 
binding for actin filament nucleation
Of the mutants we characterized, arp2-G302Y and arp3-G302Y
most dramatically inhibited ATP binding to Arp2 and Arp3, re-
spectively. Previous studies reported that ATP binding is re-
quired for Arp2/3 complex nucleation activity, but these stud-
ies were unable to tease apart the individual contributions of
ATP binding to Arp2 versus Arp3 (Dayel et al., 2001; Le
Clainche et al., 2001). Here, we demonstrated using the G302Y
mutants that ATP-bound Arp2 and Arp3 both contribute to
Arp2/3 nucleation activity in vitro. Importantly, raising the
ATP concentration to physiological levels did not increase the
in vitro nucleation activity of these mutant complexes, suggest-
ing that their nucleation activities in vivo resemble those of nu-
cleotide-free Arp2 and Arp3 complexes.
Previous studies suggested that nucleotide-bound Arp2
and Arp3 are important for WCA binding (Dayel et al., 2001).
Interestingly, arp2-G302Y and arp3-G302Y Arp2/3 complexes
bound WCA with similar affinity to the wild-type complex,
demonstrating that the decreased activity of these mutants is
not due to reduced NPF binding. A recent study probed confor-
mational states of the human Arp2/3 complex using fluores-
cence resonance energy transfer (FRET) between fluorophores
attached to different subunits of the complex (Goley et al.,
2004). Using increase in FRET to monitor WCA binding, it
was demonstrated that the arp2-D11A and arp3-D11A mutants
reduce the ability of WCA to induce conformational changes in
the Arp2/3 complex (Goley et al., 2004). Previous studies using
mutations in WCA also suggested the existence of distinct
WCA-binding and WCA-activation steps during Arp2/3 acti-
vation (Marchand et al., 2001; Panchal et al., 2003). These re-
sults support a model in which NPF-mediated Arp2/3 activa-
tion requires ATP bound to Arp2 and Arp3.
Interestingly, the arp3-D11A mutant, which was ex-
pected to bind ATP in our nucleation assays, had a similar nu-
cleation defect to the arp3-G302Y mutant. This result sug-
gested that the arp3-D11A mutation caused structural changes
in the Arp2/3 complex even when nucleotide was bound to
Arp3. Consistent with this interpretation, both the arp3-D11A
and arp3-G302Y mutants prevented conformational changes in
human Arp2/3 complex that occur upon Arp3 nucleotide bind-
ing as assessed by FRET (Goley et al., 2004). Thus, the arp3-
D11A mutant appears to uncouple conformational changes in
the Arp2/3 complex from Arp3 nucleotide binding, mimicking
the nucleotide-free arp3-G302Y mutant. The similarity of the
in vivo and in vitro phenotypes of the arp3-D11A and arp3-
G302Y mutants suggests that defects in these mutants are spe-
cifically related to Arp3 nucleotide binding. In addition, the
dramatic endocytic phenotypes seen in arp3-D11A and arp3-
G302Y demonstrate the importance of this conformational
change to Arp2/3 function in vivo.
Mechanism of Arp2/3 complex activation
Using genetic crosses of our Arp2 and Arp3 mutants, we found
that arp2-Y306A and arp3-F306A are suppressors of Arp2/3
complex defects. Interestingly, Arp2/3 complex purified from
arp2-Y306A, but not from arp3-F306A, increased the nucle-
ation activity of the Arp2/3 complex with and without Las17.
This difference in activity was also seen in vivo, as arp2-
Y306A, but not arp3-F306A, was able to suppress las17-11,
identifying a possible functional difference between Arp2 and
Arp3. Because the NBP is critical for regulating actin structure,
Figure 8. Model for nucleotide’s role in Arp2/3 complex function.
(A) Proposed relative contributions of Arp2 and Arp3 nucleotide binding to
actin filament nucleation and a yet to be determined structural activity.
(B) Proposed steps in an endocytic pathway (Merrifield et al., 2002; Kak-
sonen et al., 2003) affected by Arp2 and Arp3 nucleotide-binding mutants.
Both Arp2 and Arp3 mutants affect the initiation and the rate of actin as-
sembly at endocytic sites (i), but Arp3 mutants more dramatically inhibit
internalization of endocytic proteins as a consequence of defects in actin
network structure and integrity (ii).JCB • VOLUME 168 • NUMBER 2 • 2005 326
and because changes in the Arp2 region were visible in elec-
tron microscopy reconstructions of wild-type Arp2/3 complex
upon activation, we speculated that the arp2-Y306A mutant
causes a conformational change that increases activities of the
Arp2/3 complex.
Because  arp2-Y306A Arp2/3 complex exhibited similar
nucleation activity to wild-type Arp2/3 complex activated by
Las17 WCA, we examined the conformation of this mutant by
comparing its structure to both inactive and WCA-bound wild-
type Arp2/3 complex. Indeed, in three-dimensional reconstruc-
tions, arp2-Y306A Arp2/3 complex resembled wild-type Arp2/3
complex activated by Las17 WCA, showing a similar difference
in the region corresponding to Arp2. Previous evidence demon-
strating that NPFs enhance Arp2 nucleotide binding support a
conformational change in Arp2 upon NPF binding (Le Clainche
et al., 2001). Because it has been proposed that the Arp2/3 com-
plex must undergo a large conformational change to bring Arp2
and Arp3 together to form a template dimer (Robinson et al.,
2001; Volkmann et al., 2001), we suggest that a conformational
change in Arp2 is a critical step in this process.
It was surprising that a mutant that lowers affinity for ATP
results in Arp2/3 activation. However, this lower affinity might
indicate greater conformational flexibility of the NBP, allowing
Arp2 to adopt an active conformation in the absence of an NPF.
Interestingly, changing F306 in yeast actin to tyrosine increased
the specificity of yeast actin for ATP versus GTP (Wen et al.,
2002), possibly indicating a more compact conformation. We
also found that in addition to the arp2-Y306A mutant, the arp2-
D157E mutant also suppressed arp3 mutants. In actin, this mu-
tation has been shown to increase the nucleotide exchange rate
(Wolven et al., 2000), suggesting a more open conformation for
the NBP. We speculate that the conformational changes ob-
served in the arp2-Y306A Arp2/3 complex result from greater
conformational flexibility of the Arp2 NBP.
Function of Arp2 and Arp3 nucleotide 
binding during endocytosis: general 
biological implications
Analysis of actin organization and endocytosis in arp2-G302Y
and  arp3-G302Y demonstrated an important functional dif-
ference between nucleotide binding by Arp2 versus Arp3 in
vivo. The arp3-G302Y mutant caused severe endocytic defects,
whereas arp2-G302Y showed only slight defects. However, the
in vitro nucleation activities of these two mutants were indis-
tinguishable. Importantly, the arp3-G302Y mutant assembled
actin filaments at endocytic sites as well as arp2-G302Y, indi-
cating that nucleation of actin filaments alone is not sufficient
to drive endocytic internalization. We speculate that the struc-
ture or integrity of the cortical actin network at endocytic sites
is disrupted in Arp3 mutants.
How might Arp3 contribute to actin cortical patch integ-
rity and function? Because Arp3 nucleotide binding influences
the conformation of the Arp2/3 complex (Goley et al., 2004),
Arp3 mutants are likely to affect multiple interactions of the
Arp2/3 complex, possibly with one or several of the four known
yeast NPFs, Las17, Myo3/5, Pan1, and Abp1. Interestingly,
Myo5 appears in patches immediately preceding internalization,
suggesting that its interaction with the Arp2/3 complex plays
an important role in vesicle formation (Jonsdottir and Li,
2004). Although wild-type, arp2-G302Y, and arp3-G302Y Arp2/3
complexes bound Las17 WCA with similar affinity, conforma-
tional changes upon actin filament binding and Arp2 ATP
hydrolysis might alter interactions with NPFs subsequent to
branch formation (Marchand et al., 2001; Volkmann et al.,
2001; Le Clainche et al., 2003; Dayel and Mullins, 2004). Con-
nections between NPFs and the Arp2/3 complex in Y-branches
might anchor branched actin filaments to the plasma membrane
allowing forces to be applied for endocytic internalization. In
addition, interactions with NPFs could be important for main-
taining branched actin filament networks, such as those recently
observed in actin structures isolated from yeast (Young et al.,
2004). The phenotype of arp3-G302Y sla2  actin tails, in which
clumps of actin appeared to separate from the plasma mem-
brane, supports a defect in the integrity of plasma membrane at-
tachment, actin network integrity, or both. Discontinuous actin
comet tails have also been observed for NPF mutant “hopping”
Listeria in vivo, and using a reconstituted motility system in
vitro, although the molecular basis for this phenomenon is not
understood (Lasa et al., 1997; Bernheim-Groswasser et al.,
2002). Further analysis of the molecular interactions of Arp2
and Arp3 mutants is required to determine the mechanism by
which Arp3 mutants affect the functionality of actin patches.
Because the arp2-G302Y and arp3-G302Y mutants af-
fected in vitro nucleation activity indistinguishably, the simi-
larities between these mutants provided insight into the func-
tion of Arp2/3 complex nucleation. Both mutants exhibited a
considerable delay in the onset of actin polymerization at en-
docytic sites. This delay could have resulted from a lower nu-
cleation rate or a delay in the recruitment of the Arp2/3 com-
plex to endocytic sites. In addition, we cannot rule out the
possibility of Arp2/3-independent actin polymerization at these
sites. Interestingly, once initiated, the rate of actin assembly at
endocytic sites in arp2-G302Y and arp3-G302Y mutants was
only slightly lower in otherwise normal cells or in sla2  cells.
This observation was similar to the moderate decrease in motil-
ity rates for Listeria ActA mutants that significantly decreased
in vitro nucleation activity (Skoble et al., 2000). Therefore,
Arp2/3 nucleation activity in these contexts appears more im-
portant for initiating actin polymerization than for sustaining it.
In summary, we found that analysis of the yeast endocytic
pathway provided a sensitive assay for distinguishing functions
of the Arp2/3 complex. The similarity of the effects of our NBP
mutants of the yeast Arp2/3 complex to the analogous mutants
made in the human Arp2 and Arp3 (Goley et al., 2004), and sim-
ilarity in the recruitment of Arp2/3 complex to endocytic sites in
yeast and mammalian cells (Kaksonen et al., 2003; Merrifield et
al., 2004), suggest that our findings are directly applicable to the
function of the Arp2/3 complex in multicellular eukaryotes.
Materials and methods
Strains, media, and genetic methods
Yeast strains and plasmids used in this study are listed in Tables S2 and S3,
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Construction of mutant and tagged strains
An  ARP2::URA3 integration construct obtained from a previous study
(Madania et al., 1999), pIMW18-U, and an ARP3::LEU2 integration con-
struct, pDD1698, were mutagenized using QuikChange XL site-directed
mutagenesis kit (Stratagene). Mutants were integrated into DDY2918 and
DDY2919 as described previously (Wertman et al., 1992). Integration of
the correct allele was confirmed by change in restriction site or sequenc-
ing. ARC18 containing a COOH-terminal HA tag with a TEV protease site
was generated using pBG265 (a gift from B. Goode, Brandeis University,
Waltham, MA) and was integrated into the endogenous locus.
Protein purification
Arp2/3 complex was purified using an HA-tagged Arc18 subunit and
was stored in HEKG5 (20 mM Hepes, pH 7.5, 1 mM EDTA, 50 mM KCl,
5% glycerol) buffer. Full-length Las17 was purified as described previously
(Rodal et al., 2003). GST-tagged Las17WCA was purified from bacteria
using pDD1122. Details of these purifications and actin purification proce-
dures are provided in the supplemental materials.
ATP binding assays
ATP cross-linking was performed using 5  M ATP supplemented with 100
 Ci  -[
32P]ATP. Purified Arp2/3 complex (0.43  M) with or without WCA
(10  M) in KMEI (50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 10 mM imida-
zole, pH 7.0) was equilibrated with ATP and irradiated at a 1-cm distance
with 254 nm UV light for 5 min using a hand-held Mineralight lamp. Sam-
ples were subjected to SDS-PAGE and visualized/quantified using film or
a Typhoon 9400 Phosphorimager (Molecular Dynamics). Etheno-ATP bind-
ing was measured at 18 C using excitation and emission wavelengths of
350 and 410 nm, respectively. Increasing amounts of etheno-ATP were
added to 0.6  M Arp2/3 complex in KMEI   0.2 M acrylamide, and the
background fluorescence of unbound etheno-ATP was subtracted, as de-
scribed previously (Dayel et al., 2001). Kd values were calculated by fit-
ting the data to a one-site binding equation using GraphPad Prism (Graph-
Pad Software, Inc.).
Microscopy
Phalloidin staining, immunofluorescence, and LY uptake were per-
formed as described previously (Belmont and Drubin, 1998). For live
cell imaging, log phase cells grown at 25 C were adhered to the sur-
face of a Con A–coated coverslip, inverted onto a glass slide, and
sealed with vacuum grease (Dow Corning). All imaging was done at RT
in synthetic media. Single fluorophore images (Abp1-GFP, Sla1-GFP,
and rhodamine phalloidin) were obtained using a microscope (model
TE300; Nikon), 100 /NA 1.4 objective, and an Orca-100 Camera
(Hamamatsu) controlled by Image Pro Plus software (Phase 3 Imaging).
Dual fluorophore images (Abp1-GFP/Sla1-CFP) were obtained using a
microscope (model IX81; Olympus), 100 /NA 1.4 objective, and an
Orca-ER Camera (Hamamatsu), controlled by Slidebook 4 software (In-
telligent Imaging Innovations, Inc.). Dual fluorophore movies were ob-
tained using a CFP-YFP filter set (JP4, Chroma) and motorized excitation
and emission filter wheels (Sutter Instruments). Actin comet tails were ob-
served using a confocal microscope (model 510; Carl Zeiss MicroImag-
ing, Inc.) with a 63 /NA 1.4 objective. Photobleaching was per-
formed by scanning a small region three times at full laser intensity at
488 nm, followed by continued image acquisition at low laser intensity.
Images used to track individual Abp1 patches were smoothed by 3   3
pixel averaging and then thresholded with an adaptive thresholding al-
gorithm, which takes into account the local intensity level. Patch posi-
tions were determined by calculating the center of fluorescence intensity
for each patch. The patch positions of each frame were then connected
to trace patch trajectories. Patch intensity represents the sum of the in-
tensity of each pixel making up an individual Abp1 patch. Custom-
made software was used for all patch tracking calculations. Processing
of individual images and movies was performed using Image J software
(http://rsb.info.nih.gov/ij/).
Antibodies
Arp2 and Arp3 were detected by immunoblotting using antibodies sc-
11968 and sc-11973 (Santa Cruz Biotechnology, Inc.). Anti-HA 12CA5
(Roche) was used for immunofluorescence with Arc18-HA.
Nucleation, branching, and WCA binding assays
Actin assembly reactions were performed using 2  M actin (5% pyrene la-
beled) as described previously (Duncan et al., 2001). Barbed end concen-
trations were calculated from the rate of actin assembly at 50% polymeriza-
tion using a rate constant of 11.6  M
 1 s
 1 (Higgs et al., 1999). Branched
filaments were observed by stabilizing actin filaments after polymerization
was complete with equimolar rhodamine phalloidin (Molecular Probes) and
were processed for imaging as described previously (Amann and Pollard,
2001). Branching was quantified by first calculating total filament length us-
ing Fovea Pro 3.0 (Reindeer Graphics, Inc.) for Adobe Photoshop 7.0
(Adobe Systems, Inc.), and then counting branches manually. More than
8,000 or 13,000  m of filaments were analyzed for wild-type or Arp2/3
mutants, respectively. WCA binding was measured using glutathione
beads (Sigma-Aldrich) coated with GST-WCA. Binding was performed at
RT for 30 min in G buffer (5 mM Tris, pH 7.5, 0.2 mM ATP, 0.2 mM
CaCl2, 0.2 mM DTT) supplemented with 50 mM KCl, 2 mM MgCl2, and
0.5 mM ATP. Amounts of bound Arp3 were quantified by immunoblotting
using a Typhoon 9400 Phosphorimager (Molecular Dynamics) and Kd values
were calculated using GraphPad Prism (GraphPad Software, Inc.).
Electron microscopy
50 nM Arp2/3 complex (wild-type or arp2-Y306A mutant) was diluted in
F buffer (2 mM imidazole, pH 7.0, 50 mM KCl, 2 mM MgCl2, 1 mM
EGTA, 0.2 mM DTT, 0.1 mM ATP, 0.02% azide), applied to a carbon
coated EM grid and stained with 2% uranyl acetate. 500 nM Las17 WCA
was mixed with the wild-type Arp2/3 complex for generating the acti-
vated Arp2/3 samples. Images were obtained under low-dose conditions
using a Tecnai 12 microscope (FEI electron optics) equipped with a Lab6
filament at 120 kV at a nominal magnification of 67,000  and at  1- m
defocus. The micrographs were digitized on a SCAI scanner (Z/I Imaging)
at 7- m raster and compressed to a final pixel size of 0.6 nm.
Image processing
Interactive selection from 16, 17, and 30 micrographs yielded 2,774,
2,654, and 2,330 particles from nonactivated wild-type Arp2/3, nonacti-
vated arp2-Y306A mutant, and wild-type yeast Arp2/3 with WCA, re-
spectively. The particles were processed and analyzed using the EMAN
(Ludtke et al., 1999) and CoAn (Volkmann and Hanein, 1999; Volkmann
and Hanein, 2003) software packages. A correction for the contrast trans-
fer function was applied for all images. Particles were first sorted into 89
classes according to their mutual similarity without the use of an external
reference. Subsets of these views were used to generate initial references
using a Fourier-based common-line approach. The initial models were iter-
atively refined against the data. Convergence was achieved after 7–10 it-
erations. In addition to these reference-free models, a density map calcu-
lated from the bovine Arp2/3 crystal structure was used for separate
refinements, which converged to the same reconstructions as the data-
based models. To ensure the model independence of the differences be-
tween activated and nonactivated complex, the final reconstruction of the
activated complex was used as a starting model with the nonactivated
data and vice versa. In both cases, the distinct features of the reconstruc-
tions were recovered after a few rounds of refinement. A similar calcula-
tion was performed with the nonactivated and the mutant complex, also
with the result that the characteristic features were recovered after a few it-
erations. The crystal structure of the nonactivated bovine Arp2/3 complex
was docked into each of the reconstructions using CoAn. The correlation
between the docked structure and the reconstructions was between 84
and 85% at 2.5-nm resolution.
Online supplemental material
Supplemental videos showing Abp1, Sla1 dynamics (Videos 1 and 2),
and actin treadmilling in sla2  cells (Video 3); tables showing Arp2/3
mutant growth phenotypes (Table S1), yeast strains used in this study
(Table S2), and plasmids used in this study (Table S3); and supplemental
materials and methods are available online at http://www.jcb.org/cgi/
content/full/jcb.200408177/DC1.
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